Thailand Sperm Washing Combined with PGT: Indications, Procedure, and Reproductive Doctor Evaluation Points
Opening: Doctor's Decision Logic
In reproductive medicine clinics, when a couple has both male factor infertility and genetic screening needs, the doctor will systematically evaluate the suitability of sperm washing combined with PGT. This decision is not a routine recommendation but is based on clear medical indications—including abnormal semen parameters, viral carrier status, recurrent miscarriage history, or known genetic disease risk. The following analyzes the real application scenarios of this combined technology from the perspective of clinical decision logic.
1. What Problems Do Sperm Washing and PGT Respectively Solve?
1.1 Technical Essence and Applicable Boundaries of Sperm Washing
Sperm washing is a core laboratory technique for semen processing. It uses density gradient centrifugation, swim-up, or direct washing to separate morphologically normal, motile sperm from semen while removing seminal plasma, white blood cells, antisperm antibodies, bacteria, and viral particles. Clinically, it is mainly used in the following scenarios:
- Severe oligo-, astheno-, teratozoospermia: Density gradient centrifugation can significantly improve the recovery rate of high-quality sperm.
- Semen infection or leukocytospermia: Removes inflammatory cells and reactive oxygen species, reducing sperm DNA damage.
- Viral carriers (HIV, HBV, HCV): Combined with PCR testing after washing to reduce the risk of viral transmission.
- Positive antisperm antibodies: Washing removes antibodies attached to the sperm surface.
- Elevated sperm DNA fragmentation rate (DFI): In some cases, washing can reduce DFI, but the effect varies individually.
Sperm washing cannot change the sperm's own genetic material or repair chromosomal abnormalities. It addresses the issues of the semen "transport environment" and "functional selection," not the genetic quality itself.
1.2 Clinical Positioning of PGT
Preimplantation genetic testing (PGT) is divided into PGT-A (aneuploidy screening), PGT-M (monogenic disease testing), and PGT-SR (structural rearrangement testing). Its core value lies in screening embryos with normal chromosome copy numbers or those not carrying pathogenic genes before embryo transfer, thereby improving implantation rates, reducing miscarriage rates, and avoiding the transmission of genetic diseases.
PGT does not benefit all populations. Current consensus indicates clear benefits for the following groups: women aged ≥38 years, ≥2 recurrent spontaneous miscarriages, recurrent implantation failure, known chromosomal structural abnormalities, or carriers of monogenic diseases. For young patients without clear indications, PGT does not improve cumulative live birth rates and may cause embryo damage due to biopsy.
2. When Is Sperm Washing Combined with PGT Needed?
The medical logic for combining the two technologies is: when male sperm quality or infection status affects ICSI fertilization and embryo developmental potential, and the couple has genetic risks, stepwise processing is necessary to achieve optimal outcomes. Specific applicable scenarios include:
| Applicable Scenario | Key Clinical Features | Value of Combined Treatment |
|---|---|---|
| Severe oligoasthenoteratozoospermia + Advanced maternal age | Sperm concentration <5×10⁶/mL, or motility <10%, female age ≥38 years | Sperm washing selects high-quality sperm for ICSI, PGT-A screens euploid embryos to compensate for uncertainty in embryo quality |
| HIV-positive male + Family history of genetic disease | Stable viral load, normal CD4 count, and need to rule out specific monogenic diseases | Sperm washing + PCR confirmation negative before ICSI, PGT-M blocks transmission of genetic disease |
| Recurrent miscarriage + Persistently elevated sperm DFI | ≥2 miscarriages, DFI >30%, and normal female karyotype | Sperm washing reduces DFI (partially effective), PGT-A screens euploid embryos to reduce risk of another miscarriage |
| Male chromosomal structural abnormality + Abnormal semen parameters | Balanced translocation, Robertsonian translocation, etc., accompanied by oligoasthenozoospermia | Sperm washing improves sperm quality for ICSI, PGT-SR screens for normal/balanced carrier embryos |
Cases Where Combined Use Is Not Suitable
- Severely diminished ovarian reserve in female: AMH <0.5 ng/mL, expected number of retrieved oocytes ≤3, may result in no embryo available for transfer after PGT.
- Basically normal semen parameters and no genetic risk: Using the combination solely to "improve success rate" lacks medical evidence.
- Uncontrolled active infection: e.g., HIV viral load not suppressed, HBV DNA positive; need to stabilize medically first before evaluation.
- Unrealistic psychological expectations: Believing "sperm washing + PGT will definitely succeed," ignoring core variables such as age and egg quality.
3. Thailand's Technical Environment and Differences from China
Thailand developed early in the field of assisted reproduction, with technology mainly introduced from Europe and the United States, accumulating considerable clinical experience in sperm washing and PGT. The following outlines the main differences between Thailand and China from a technical perspective:
| Comparison Dimension | Thailand | China |
|---|---|---|
| Prevalence of Sperm Washing Technology | Mainstream reproductive centers have density gradient centrifugation + swim-up capability; mature process for HIV sperm washing | Routinely performed in tertiary hospital reproductive centers, but HIV sperm washing is policy-restricted, only in a few designated institutions |
| PGT Policy Environment | Relatively broad indications; PGT-A, PGT-M, PGT-SR available without strict approval | Strictly defined indications; requires ethical approval; PGT-A only for clear indications like advanced age, recurrent miscarriage |
| Laboratory Quality Control System | Varies greatly between hospitals; some institutions have JCI or ISO certification, but not mandatory | Regulated by the National Health Commission; laboratories must undergo regular quality control inspections; unified standards |
| Embryo Culture and Biopsy Technology | Commonly uses blastocyst culture + laser-assisted biopsy; NGS testing is mainstream | Also mainly blastocyst biopsy + NGS; no technological gap |
| Acceptance of Infected Patients | HIV, HBV, HCV positive patients can receive treatment with dedicated procedures | HIV positive patients need to visit designated hospitals; some centers do not accept them |
4. Actual Procedure and Timeline
The complete cycle of sperm washing combined with PGT is divided into the following stages, each with clear medical milestones:
Stage 1: Preliminary Evaluation and Preparation (4-6 weeks)
- Female: AMH, FSH, LH, E2, antral follicle count, karyotype, genetic carrier screening, infectious disease panel, hysteroscopy (if necessary).
- Male: Semen analysis + morphology + DFI, karyotype, Y chromosome microdeletion, infectious disease panel, pre-wash viral load (for infected individuals).
- Couple: Genetic counseling (if family history), signing informed consent.
Stage 2: Ovarian Stimulation and Egg Retrieval (10-14 days)
- Female starts ovarian stimulation on day 2-3 of menstrual cycle; regular monitoring of follicle development and hormone levels.
- Egg retrieval 36 hours after trigger; male provides semen sample simultaneously.
Stage 3: Sperm Washing and ICSI (1 day)
- Semen sample sent to laboratory; processed using density gradient centrifugation or swim-up method.
- For virus carriers, supernatant is tested by PCR after washing; used for ICSI only after confirmed negative.
- Select morphologically normal, motile sperm for ICSI fertilization.
Stage 4: Blastocyst Culture and PGT Testing (14-21 days)
- Culture to day 5-6 for blastocyst formation; laser-assisted biopsy performed on blastocysts meeting biopsy quality standards.
- Biopsied cells sent for NGS testing (PGT-A or PGT-M/SR); blastocysts are cryopreserved simultaneously.
- Testing cycle typically takes 10-14 working days.
Stage 5: Frozen Embryo Transfer (Subsequent Menstrual Cycle)
- Endometrial preparation (natural cycle or hormone replacement cycle); endometrial receptivity assessed.
- Select embryos with normal chromosomes or not carrying pathogenic genes for thawing and transfer.
- Pregnancy test 12-14 days after transfer.
| Stage | Time Required | Key Considerations |
|---|---|---|
| Preliminary Examinations | 4-6 weeks | Some tests have validity periods (e.g., infectious disease screening within 6 months); must align with treatment timing |
| Ovarian Stimulation + Egg Retrieval | 10-14 days | Older age and lower ovarian reserve may prolong stimulation duration |
| Sperm Washing + ICSI | 1 day | Infected patients need to confirm viral load and post-wash PCR testing plan in advance |
| Blastocyst Culture + PGT | 2-3 weeks | At least 3-5 blastocysts needed for testing; otherwise, no embryo may be available for transfer |
| Frozen Embryo Transfer | 1-2 weeks (endometrial preparation) | Transfer cycle timing depends on endometrial status and hormone levels |
5. Most Easily Overlooked Clinical Details
- Re-evaluation of sperm quality after washing: Washing is not effective for all DFI elevations. In some patients, DFI may increase after washing (due to centrifugal force damage); recheck DFI after washing to confirm.
- Threshold number of embryos for PGT testing: When the number of blastocysts sent for testing is <3, the probability of obtaining a euploid embryo drops significantly; be mentally prepared.
- Post-wash confirmation for infected patients: PCR testing after HIV sperm washing has a window period; some centers perform two tests to ensure safety.
- Logic for choosing a hospital in Thailand: Laboratory quality is more important than hospital reputation. Check if the lab has HSS (High Safety Sperm Processing) certification or similar quality control systems.
- Necessity of genetic counseling: PGT-M and PGT-SR require identifying the pathogenic gene or breakpoints first; some families need preliminary testing, which takes 1-3 months.
6. Common Cognitive Misconceptions
- "Sperm washing can change sperm genetic quality": Washing is physical selection; it does not alter sperm DNA itself. For embryo abnormalities caused by genetic factors, washing has no improvement effect.
- "PGT guarantees success": PGT screens for chromosomally normal embryos, but embryo implantation is also affected by uterine environment, immune factors, endocrine status, etc.; it cannot guarantee 100% pregnancy.
- "PGT success rates are higher in Thailand than in China": The technology itself has no gap; differences lie mainly in indication flexibility and acceptance of infected patients. Success rate depends on variables like patient age, ovarian reserve, sperm quality, not geographical location.
- "Sperm washing + PGT can solve all infertility problems": This approach is only for specific indications. Different treatment paths are needed for ovulation disorders, tubal factors, endometriosis, etc.
7. Frequently Asked Questions
Q1: How effective is sperm washing in improving sperm DNA fragmentation rate (DFI)?
Improvement varies individually. Density gradient centrifugation can remove some sperm with high fragmentation, but improvement is limited in patients with DFI >40%. It is recommended to test DFI after washing; if still >30%, consider extending abstinence time (2-3 days) or using antioxidant therapy before trying again.
Q2: How long does the entire process of sperm washing + PGT in Thailand take?
From initial consultation to the end of transfer, it usually takes 8-12 weeks. This includes 4-6 weeks for preliminary examinations, 2 weeks for stimulation and egg retrieval, 2-3 weeks for PGT testing, and 2 weeks for the transfer cycle. Time may be extended due to individual differences and testing items.
Q3: If the sperm count is low after washing, can ICSI still be performed?
Yes. ICSI requires only one morphologically normal, motile sperm. Even if only a small number of sperm are recovered after washing, as long as morphology and motility are adequate, the ICSI fertilization rate is not affected.
Q4: What are the costs for sperm washing + PGT in Thai hospitals?
The fee structure typically includes: sperm washing technical fee (based on complexity of semen processing), ICSI fee, blastocyst culture fee, PGT testing fee (based on number of embryos tested), and cryopreservation fee. Total cost varies depending on the hospital, number of embryos tested, and additional services. It is recommended to obtain a detailed fee list before treatment.
8. Key Points for Special Populations
| Population | Key Points |
|---|---|
| HIV-positive male | Sperm washing + dual PCR confirmation; viral load must be <50 copies/mL, CD4 >350 cells/μL; coordinated management with infectious disease department |
| HBsAg positive | Washing can remove free virus, but semen HBV DNA should be tested; infant needs immunoglobulin + vaccine after birth |
| Sperm DFI >40% | DFI may still be high after washing; consider testicular sperm aspiration (epididymal/testicular sperm usually has lower DFI) |
| Advanced maternal age (≥42 years) | PGT-A benefit is clear, but fully inform about low oocyte yield, low euploidy rate, and high risk of cycle cancellation |
| Recurrent implantation failure | Need to investigate uterine factors, immune abnormalities, endometrial receptivity; PGT only addresses embryo factors and cannot replace other tests |
This article is compiled by the Reproductive Medicine Editorial Team based on assisted reproductive clinical guidelines and publicly available medical literature. It aims to provide an objective technical analysis and does not constitute medical advice. Specific treatment plans should be formulated by a reproductive doctor based on individual circumstances.
References: ESHRE PGT Guidelines (2023), ASRM Male Infertility Evaluation Recommendations (2022), Thai Society for Reproductive Medicine (TSRM) Technical Consensus.
